European Innovation Council

VSORA is an intellectual property provider based in France, specializing in digital signal processing (DSP) technology for semiconductor chips used in advanced digital communications systems, including 5G networks. Founded in 2015 by a team of experienced DSP engineers, the company offers a powerful multi-core DSP architecture that eliminates the need for DSP co-processors, allowing for greater flexibility akin to software programming. VSORA's innovative DSP development flow facilitates collaboration between signal processing and software engineers, significantly accelerating time-to-market for new products. The company focuses on enhancing DSP computing power while optimizing power consumption and performance, ultimately reducing the silicon footprint required for complex integrated circuits.

Wooptix S.L., founded in 2014 and headquartered in Madrid, Spain, specializes in developing advanced imaging technologies. The company focuses on light field and wavefront phase imaging software that captures comprehensive information about light, utilizing the full resolution of sensors. Wooptix's platform enables the three-dimensional modulation of images, allowing for higher data points at elevated frame rates in volumetric images and videos. This technology facilitates enhanced image quality and advanced post-processing capabilities, providing users with innovative ways to interact with and visualize their environments. Wooptix aims to improve human experiences through its cutting-edge imaging solutions.

TENSIVE s.r.l. is a biomedical company based in Milan, Italy, founded in 2012. It specializes in the development of innovative prostheses for natural breast reconstruction and augmentation. The company's products utilize biodegradable synthetic biomaterials and feature an internal micro-architecture that mimics blood vessel structures. These vascularized prostheses aim to enhance the quality of life for patients undergoing treatment for breast cancer, offering a solution that reduces the need for recurrent and costly surgical interventions. Through its focus on advanced biomaterials and design, TENSIVE seeks to provide effective and sustainable options for breast reconstruction.

Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

INBRAIN Neuroelectronics is a medical device company based in Barcelona, Spain, founded in 2019. It specializes in developing graphene-based neural interfaces and intelligent neuromodulation systems aimed at treating brain disorders. The company has created the world's first graphene-based brain-computer interface (BCI) therapeutics platform, which integrates precise BCI decoding with micrometric modulation. This innovative technology allows for real-time monitoring and adaptive, personalized treatments for conditions such as Parkinson's disease, epilepsy, and stroke rehabilitation. By utilizing AI-driven solutions, INBRAIN maximizes therapeutic outcomes while minimizing side effects. The company is also expanding its capabilities through strategic partnerships, including collaborations with Merck KGaA and its subsidiary INNERVIA Bioelectronics, to explore applications in peripheral nerve and systemic diseases, advancing the field of neurotechnology and bioelectronics.

Axelera AI is a company focused on advancing artificial intelligence through its specialized hardware and software platforms, particularly for edge computing applications. Its flagship product, the Metis™ AI Platform, combines innovative hardware and software to offer high-performance and energy-efficient AI inference solutions. Recognized for its innovation, the platform was honored at the CES® 2024 Innovation Awards. Established in 2021, Axelera AI was incubated by Bitfury, a leader in emerging technologies, and partnered with imec, a prominent nano-technology group. The company is headquartered in the AI Innovation Center at the High Tech Campus in Eindhoven, with research and development offices located in Belgium, Switzerland, and Italy. The team consists of experts in AI software and hardware, many of whom have backgrounds with leading AI firms and Fortune 500 companies. Axelera AI’s platform features a unique custom dataflow architecture with multicore in-memory computing, enabling clients to achieve optimal power efficiency while supporting various networks for sustainable edge applications.

Tilkal is a Paris-based company founded in 2017 that specializes in supply chain traceability and trust solutions for Industry 4.0. The company has developed a software infrastructure that organizes traceability data across various supply chain stakeholders, utilizing a unique B2B blockchain network to facilitate secure and verifiable data sharing. Tilkal's platform incorporates analytics and scoring algorithms to provide an end-to-end, real-time representation of supply chains. This enables businesses to address critical questions regarding product location, sourcing risks, ESG commitments, and compliance verification. Prominent clients include Danone, Daher, Joone, and the NGO Responsible Mica Initiative, which leverage Tilkal's capabilities for diverse applications such as tracing infant milk sourcing and analyzing mica supply chains. The Tilkal network comprises over 70 independent nodes and serves nearly 700 companies, reinforcing its role in promoting resilience, sustainability, and ethical practices within supply chains.

Ability Pharmaceuticals is a drug discovery and development company based in Barcelona, Spain. It develops human therapeutics targeting cell membranes to treat cancer and other indications with unmet medical needs. Ability Pharmaceuticals is focused on developing new drugs for the treatment of lung cancer and pancreatic cancer. The company develops Lipid Analogue Therapeutics, a new drug class that modifies the composition of the cell membrane and displays a capacity to influence the local organization of lipid structures in the cell membrane, inducing the formation of non-lamellar phase structures. Its development pipeline includes ABTL0812 product in preclinical development; and ABTL1014, a drug candidate in preclinical characterization.

Multiverse Computing SL is a software development company based in San Sebastian, Spain, with an additional office in Toronto, Canada. Established in 2019, the company specializes in creating quantum computing software that leverages probabilistic and nondeterministic technologies to address complex challenges in various sectors, particularly finance. Multiverse Computing's software solutions are designed for portfolio optimization, risk analysis, and market simulation, enabling clients in industries such as banking, energy, manufacturing, and logistics to harness the power of quantum computing. By focusing on these tailored applications, the company aims to facilitate advancements in solving financial and macro-economic problems, positioning itself as a key player in the emerging quantum technology landscape.

Daze is an engineering startup focused on creating innovative solutions for electric vehicle charging. Its flagship product, DazePlug, is an automatic charging device that utilizes smart charging ecosystems and energy management systems. This technology enables automatic inductive charging, significantly reducing the time required to charge electric vehicles while eliminating the need for manual handling of cables. DazePlug features a retrofit design that is both waterproof and dustproof, ensuring durability and ease of use. By simplifying the charging process, Daze aims to enhance user experience and convenience for electric vehicle owners.

Palobiofarma is a Spanish biotechnology company based in Barcelona’s Science Park, dedicated to discovering and developing innovative drugs that target adenosine receptors. The company aims to be the first European entity to bring an adenosine modulator to market, focusing on the treatment of diseases such as advanced prostate cancer. Through its expertise in medicinal chemistry and in vitro pharmacology, Palobiofarma is committed to advancing the understanding of adenosine's role in disease and enabling healthcare professionals to improve patient outcomes through novel therapeutic options.

NETRIS Pharma S.A.S. is a biotechnology company based in Lyon, France, focused on the identification and development of therapeutic molecules aimed at treating various forms of cancer. Established in 2008, the company specializes in targeting dependence receptors, which are trans-membrane proteins that play a crucial role in cellular signaling and tumor control. NETRIS Pharma conducts both in vitro and in vivo research, as well as preclinical practices, to manufacture drugs specifically for the treatment of breast cancer, lung cancer, glioblastoma, and neuroblastoma. Through its innovative approach, the company aims to advance cancer therapies and contribute to improved patient outcomes in the pharmaceutical industry.

Antabio is a private biopharmaceutical company based in Labege, France, focused on developing innovative treatments for drug-resistant infections, particularly targeting critical priority pathogens. Founded in 2009, the company specializes in creating novel antibacterial resistance-breakers, including stand-alone inhibitors of bacterial metalloenzymes. These inhibitors are designed to be combined with existing antibiotics, such as carbapenems, to restore their efficacy against the most challenging pathogens responsible for life-threatening infections, including carbapenem-resistant nosocomial pneumonia. Antabio aims to address significant unmet medical needs in the treatment of drug-resistant infections, ultimately providing healthcare professionals with effective medicinal products to combat these critical health challenges. The company has been recognized for its work, receiving a Wellcome Trust Seeding Drug Discovery Award.

Ignion is an antenna innovator based in Sant Cugat del Vallès, Spain, founded in 2015. The company specializes in the manufacturing of multiband, multipurpose antennas designed to address mobile and wireless connectivity needs. Ignion provides off-the-shelf antennas that cater to the Internet of Things and short-range wireless devices, particularly suited for indoor environments. Their products are designed for easy and efficient integration into industrial designs, enabling clients to meet their connectivity requirements effectively.

VSORA is an intellectual property provider based in France, specializing in digital signal processing (DSP) technology for semiconductor chips used in advanced digital communications systems, including 5G networks. Founded in 2015 by a team of experienced DSP engineers, the company offers a powerful multi-core DSP architecture that eliminates the need for DSP co-processors, allowing for greater flexibility akin to software programming. VSORA's innovative DSP development flow facilitates collaboration between signal processing and software engineers, significantly accelerating time-to-market for new products. The company focuses on enhancing DSP computing power while optimizing power consumption and performance, ultimately reducing the silicon footprint required for complex integrated circuits.

Epigene Labs SAS is a biotechnology firm focused on enhancing precision oncology through its advanced technology platform that utilizes artificial intelligence. Founded in 2019 and headquartered in Paris, France, with an additional office in Boston, Massachusetts, the company addresses the significant challenges of aggregating, analyzing, and visualizing extensive genomic data in cancer research. By integrating proprietary data from partners with publicly available datasets, Epigene Labs provides medical researchers with actionable insights and user-friendly analytics. The company collaborates with leading cancer centers and prominent biotech firms to develop intelligence-augmenting services that support drug discovery and research in precision oncology. Its innovative approach aims to transform genomic data into effective strategies for targeted cancer therapies.

INBRAIN Neuroelectronics is a medical device company based in Barcelona, Spain, founded in 2019. It specializes in developing graphene-based neural interfaces and intelligent neuromodulation systems aimed at treating brain disorders. The company has created the world's first graphene-based brain-computer interface (BCI) therapeutics platform, which integrates precise BCI decoding with micrometric modulation. This innovative technology allows for real-time monitoring and adaptive, personalized treatments for conditions such as Parkinson's disease, epilepsy, and stroke rehabilitation. By utilizing AI-driven solutions, INBRAIN maximizes therapeutic outcomes while minimizing side effects. The company is also expanding its capabilities through strategic partnerships, including collaborations with Merck KGaA and its subsidiary INNERVIA Bioelectronics, to explore applications in peripheral nerve and systemic diseases, advancing the field of neurotechnology and bioelectronics.

Scipio Bioscience SAS is a biotechnology company based in Paris, France, founded in 2017. It specializes in manufacturing benchtop kits that provide innovative sample preparation solutions for single-cell studies. These kits are designed for use in sequencing applications across both clinical and basic research, with a particular focus on transcriptomics. Scipio Bioscience's products enable research laboratories to perform single-cell barcoding in a test tube format, facilitating more precise and efficient analysis in various scientific investigations.

Wooptix S.L., founded in 2014 and headquartered in Madrid, Spain, specializes in developing advanced imaging technologies. The company focuses on light field and wavefront phase imaging software that captures comprehensive information about light, utilizing the full resolution of sensors. Wooptix's platform enables the three-dimensional modulation of images, allowing for higher data points at elevated frame rates in volumetric images and videos. This technology facilitates enhanced image quality and advanced post-processing capabilities, providing users with innovative ways to interact with and visualize their environments. Wooptix aims to improve human experiences through its cutting-edge imaging solutions.

Wooptix S.L., founded in 2014 and headquartered in Madrid, Spain, specializes in developing advanced imaging technologies. The company focuses on light field and wavefront phase imaging software that captures comprehensive information about light, utilizing the full resolution of sensors. Wooptix's platform enables the three-dimensional modulation of images, allowing for higher data points at elevated frame rates in volumetric images and videos. This technology facilitates enhanced image quality and advanced post-processing capabilities, providing users with innovative ways to interact with and visualize their environments. Wooptix aims to improve human experiences through its cutting-edge imaging solutions.

Energy Dome is an Italian company based in Lonate Pozzolo, Lombardy, that specializes in innovative energy storage technology aimed at addressing climate change. The company has developed a low-cost and efficient system for long-duration electricity storage utilizing liquid carbon dioxide. This technology employs a thermodynamic transformation of carbon dioxide in a closed-loop process, allowing for the storage of energy and making renewable power more dispatchable. Energy Dome's focus is on enhancing renewable energy production's affordability and reliability, contributing to the decarbonization of the energy sector and promoting a more sustainable future.

ADmit Therapeutics, S.L. is a biotechnology company based in Begues, Spain, focused on developing diagnostic tests for the early detection of Alzheimer’s disease. Founded in 2017, the company utilizes epigenetic analysis of blood samples to identify a series of mitochondrial biomarkers, which are unrelated to traditional markers such as ß-amyloid or tau. By employing next-generation sequencing to analyze methylcytosines in mitochondrial DNA, ADmit Therapeutics provides medical practitioners with a simplified method for detecting early-stage Alzheimer’s disease. This innovative approach not only aids in diagnosis but also supports pharmaceutical companies in the accelerated identification of potential curative drugs.

Voiseed is an Italian startup focused on artificial intelligence in synthetic speech technology. The company has developed a fast and scalable AI Dubbing Platform specifically for the video game industry, enabling the creation of virtual human voices that mimic human emotions and prosody. This cloud-based software leverages advanced generative AI technologies to produce highly expressive virtual voices, allowing creators to customize vocal expressions and achieve multilingual voice conversion for various projects. By streamlining the dubbing process, Voiseed aims to reduce costs, time, and complexity, while continuously expanding its features to cater to additional sectors beyond gaming.

Ganymed Robotics SAS, established in 2018 and headquartered in Paris, France, specializes in the development of advanced robotics technologies tailored for orthopedic surgeons. The company's primary focus is on creating a therapeutic device designed to enhance surgical precision during knee replacement procedures. This innovative technology aims to improve patient outcomes, surgeon experience, and overall efficiency of care delivery by leveraging robotic assistance to reduce operating time.

Daze is an engineering startup focused on creating innovative solutions for electric vehicle charging. Its flagship product, DazePlug, is an automatic charging device that utilizes smart charging ecosystems and energy management systems. This technology enables automatic inductive charging, significantly reducing the time required to charge electric vehicles while eliminating the need for manual handling of cables. DazePlug features a retrofit design that is both waterproof and dustproof, ensuring durability and ease of use. By simplifying the charging process, Daze aims to enhance user experience and convenience for electric vehicle owners.

Energy Dome is an Italian company based in Lonate Pozzolo, Lombardy, that specializes in innovative energy storage technology aimed at addressing climate change. The company has developed a low-cost and efficient system for long-duration electricity storage utilizing liquid carbon dioxide. This technology employs a thermodynamic transformation of carbon dioxide in a closed-loop process, allowing for the storage of energy and making renewable power more dispatchable. Energy Dome's focus is on enhancing renewable energy production's affordability and reliability, contributing to the decarbonization of the energy sector and promoting a more sustainable future.

Nexdot is a company specializing in the development and production of semiconductor nanocrystals known as Quantum Dots, with a particular focus on nanoplatelets—two-dimensional nanosheet Quantum Dots that exhibit enhanced properties. Originating as a spin-off from a renowned academic laboratory in Paris, Nexdot leverages over a decade of expertise in nanomaterial research. The company has invested four years in intensive research and development to establish unique capabilities in the synthesis of colloidal Quantum Dots and Nanoplatelets. Their proprietary materials, characterized by controlled shape and composition, are designed for a variety of applications, including displays, lighting, energy storage, detectors, and bio-imaging. Nexdot combines a team of highly skilled, passionate scientists with seasoned executives who possess a strong background in management and innovation leadership, positioning the company as a leader in the field.

Carmat is a French medtech company that specializes in the development and manufacturing of bioprosthetic artificial hearts. Founded in 2008 and headquartered in Vélizy-Villacoublay, the company creates biocompatible, auto-regulated total artificial hearts designed to closely mimic the human heart's structure, including both right and left ventricles. These devices are intended for patients suffering from chronic terminal heart failure classified as class IV by the New York Heart Association, as well as those experiencing acute terminal heart failure due to massive myocardial infarction. Carmat aims to provide a reliable and innovative therapeutic solution for heart failure patients who are ineligible for transplants and have exhausted other treatment options. In addition to the artificial hearts, the company develops the necessary power supply systems and remote diagnostic systems for these devices.

TENSIVE s.r.l. is a biomedical company based in Milan, Italy, founded in 2012. It specializes in the development of innovative prostheses for natural breast reconstruction and augmentation. The company's products utilize biodegradable synthetic biomaterials and feature an internal micro-architecture that mimics blood vessel structures. These vascularized prostheses aim to enhance the quality of life for patients undergoing treatment for breast cancer, offering a solution that reduces the need for recurrent and costly surgical interventions. Through its focus on advanced biomaterials and design, TENSIVE seeks to provide effective and sustainable options for breast reconstruction.

Newronika is a company dedicated to restoring brain and body functions through innovative neuro-modulation technologies. It translates extensive expertise in biosignal decoding into clinical applications aimed at enhancing treatments, health, and overall wellness. By utilizing a therapeutic device that employs a retro-activity system, Newronika records brain activity and modulates neuro-stimulation to analyze and interpret bio-signals. This technology ensures that patients receive the appropriate stimulation at critical moments, enabling them to engage in normal daily activities and improve their quality of life. Founded as a spin-off from two prominent Italian research institutions, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan, Newronika prides itself on a multidisciplinary team of scientists specializing in various fields, including neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.

Carmat is a French medtech company that specializes in the development and manufacturing of bioprosthetic artificial hearts. Founded in 2008 and headquartered in Vélizy-Villacoublay, the company creates biocompatible, auto-regulated total artificial hearts designed to closely mimic the human heart's structure, including both right and left ventricles. These devices are intended for patients suffering from chronic terminal heart failure classified as class IV by the New York Heart Association, as well as those experiencing acute terminal heart failure due to massive myocardial infarction. Carmat aims to provide a reliable and innovative therapeutic solution for heart failure patients who are ineligible for transplants and have exhausted other treatment options. In addition to the artificial hearts, the company develops the necessary power supply systems and remote diagnostic systems for these devices.

INBRAIN Neuroelectronics is a medical device company based in Barcelona, Spain, founded in 2019. It specializes in developing graphene-based neural interfaces and intelligent neuromodulation systems aimed at treating brain disorders. The company has created the world's first graphene-based brain-computer interface (BCI) therapeutics platform, which integrates precise BCI decoding with micrometric modulation. This innovative technology allows for real-time monitoring and adaptive, personalized treatments for conditions such as Parkinson's disease, epilepsy, and stroke rehabilitation. By utilizing AI-driven solutions, INBRAIN maximizes therapeutic outcomes while minimizing side effects. The company is also expanding its capabilities through strategic partnerships, including collaborations with Merck KGaA and its subsidiary INNERVIA Bioelectronics, to explore applications in peripheral nerve and systemic diseases, advancing the field of neurotechnology and bioelectronics.

INBRAIN Neuroelectronics is a medical device company based in Barcelona, Spain, founded in 2019. It specializes in developing graphene-based neural interfaces and intelligent neuromodulation systems aimed at treating brain disorders. The company has created the world's first graphene-based brain-computer interface (BCI) therapeutics platform, which integrates precise BCI decoding with micrometric modulation. This innovative technology allows for real-time monitoring and adaptive, personalized treatments for conditions such as Parkinson's disease, epilepsy, and stroke rehabilitation. By utilizing AI-driven solutions, INBRAIN maximizes therapeutic outcomes while minimizing side effects. The company is also expanding its capabilities through strategic partnerships, including collaborations with Merck KGaA and its subsidiary INNERVIA Bioelectronics, to explore applications in peripheral nerve and systemic diseases, advancing the field of neurotechnology and bioelectronics.

ELEM Biotech SL is a biomedical software company based in Barcelona, Spain, that specializes in creating virtual human models through advanced mathematical modeling and cloud computing. Founded in 2018 by researchers from the Barcelona Supercomputing Center, ELEM has developed a suite of simulation tools known as Alya Red. This platform operates on a Software-as-a-Service model and is designed for the medical device and pharmaceutical industries. Alya Red allows for the simulation of cardiovascular and respiratory systems on virtual patients, utilizing high-performance computing, computational biomechanics, and data analysis. These virtual avatars enable biomedical companies and healthcare professionals to enhance diagnostics, plan treatments, optimize drug delivery, and improve medical devices.

CAILabs SAS is a French deep tech company headquartered in Rennes, specializing in the design, development, and production of photonic solutions aimed at optimizing light utilization in various applications. Established in 2013, CAILabs focuses on innovative optical components, particularly through its patented Multi-Plane Light Conversion (MPLC) technology. The company provides a range of products, including mode multiplexers, light converters, and laser beam shaping solutions tailored for the telecommunications and industrial laser sectors. Its offerings are designed to enhance the performance of fiber optic networks and laser material processing, addressing critical challenges such as atmospheric turbulence and the need for efficient signal multiplexing. CAILabs aims to leverage its expertise and technological innovations to create reliable and cost-effective solutions for clients in the photonics industry.

ROSI is a company based in Grenoble, France, focused on developing innovative technologies for the recycling and revalorization of raw materials within the photovoltaic industry. The company specializes in recovering ultra-pure silicon and other metals that are typically lost during the manufacturing of photovoltaic cells and at the end of a solar panel's life cycle. By addressing industrial waste generated during the solar wafer slicing process and capturing silicon fine particles lost during PV-silicon production, ROSI enables its clients to produce photovoltaic modules in a more sustainable and cost-effective manner.

APIX Analytics is a company specializing in the development and marketing of advanced gas analyzer systems. Founded in 2014 and based in Grenoble, France, APIX Analytics focuses on creating miniaturized multigas analyzers using nano-silicon technology. These systems are designed for industrial, environmental, and security applications, integrating analytical chains such as sampling, gas injection, and separation of complex gas mixtures to enhance specificity and detection. The company's technology aims to improve the identification and quantification of each compound in a mixture, thereby increasing safety and quality requirements for various industries, including renewable energy development.

Energy Dome is an Italian company based in Lonate Pozzolo, Lombardy, that specializes in innovative energy storage technology aimed at addressing climate change. The company has developed a low-cost and efficient system for long-duration electricity storage utilizing liquid carbon dioxide. This technology employs a thermodynamic transformation of carbon dioxide in a closed-loop process, allowing for the storage of energy and making renewable power more dispatchable. Energy Dome's focus is on enhancing renewable energy production's affordability and reliability, contributing to the decarbonization of the energy sector and promoting a more sustainable future.

Fineheart is a France-based medical device company specializing in innovative technologies for cardiovascular care. It focuses on the development of implantable cardiac devices aimed at treating cardiovascular diseases. The company's flagship product is a novel, wirelessly powered, fully implantable mechanical circulatory support device. This device is designed to optimize cardiac output while preserving the heart's natural contractility, thereby enabling patients to restore normal cardiac function. Fineheart's technology aims to improve the quality of life for heart failure patients, allowing them to return to normal daily activities.

Fineheart is a France-based medical device company specializing in innovative technologies for cardiovascular care. It focuses on the development of implantable cardiac devices aimed at treating cardiovascular diseases. The company's flagship product is a novel, wirelessly powered, fully implantable mechanical circulatory support device. This device is designed to optimize cardiac output while preserving the heart's natural contractility, thereby enabling patients to restore normal cardiac function. Fineheart's technology aims to improve the quality of life for heart failure patients, allowing them to return to normal daily activities.

Tilkal is a Paris-based company founded in 2017 that specializes in supply chain traceability and trust solutions for Industry 4.0. The company has developed a software infrastructure that organizes traceability data across various supply chain stakeholders, utilizing a unique B2B blockchain network to facilitate secure and verifiable data sharing. Tilkal's platform incorporates analytics and scoring algorithms to provide an end-to-end, real-time representation of supply chains. This enables businesses to address critical questions regarding product location, sourcing risks, ESG commitments, and compliance verification. Prominent clients include Danone, Daher, Joone, and the NGO Responsible Mica Initiative, which leverage Tilkal's capabilities for diverse applications such as tracing infant milk sourcing and analyzing mica supply chains. The Tilkal network comprises over 70 independent nodes and serves nearly 700 companies, reinforcing its role in promoting resilience, sustainability, and ethical practices within supply chains.

Tilkal is a Paris-based company founded in 2017 that specializes in supply chain traceability and trust solutions for Industry 4.0. The company has developed a software infrastructure that organizes traceability data across various supply chain stakeholders, utilizing a unique B2B blockchain network to facilitate secure and verifiable data sharing. Tilkal's platform incorporates analytics and scoring algorithms to provide an end-to-end, real-time representation of supply chains. This enables businesses to address critical questions regarding product location, sourcing risks, ESG commitments, and compliance verification. Prominent clients include Danone, Daher, Joone, and the NGO Responsible Mica Initiative, which leverage Tilkal's capabilities for diverse applications such as tracing infant milk sourcing and analyzing mica supply chains. The Tilkal network comprises over 70 independent nodes and serves nearly 700 companies, reinforcing its role in promoting resilience, sustainability, and ethical practices within supply chains.

Nexdot is a company specializing in the development and production of semiconductor nanocrystals known as Quantum Dots, with a particular focus on nanoplatelets—two-dimensional nanosheet Quantum Dots that exhibit enhanced properties. Originating as a spin-off from a renowned academic laboratory in Paris, Nexdot leverages over a decade of expertise in nanomaterial research. The company has invested four years in intensive research and development to establish unique capabilities in the synthesis of colloidal Quantum Dots and Nanoplatelets. Their proprietary materials, characterized by controlled shape and composition, are designed for a variety of applications, including displays, lighting, energy storage, detectors, and bio-imaging. Nexdot combines a team of highly skilled, passionate scientists with seasoned executives who possess a strong background in management and innovation leadership, positioning the company as a leader in the field.

ELEM Biotech SL is a biomedical software company based in Barcelona, Spain, that specializes in creating virtual human models through advanced mathematical modeling and cloud computing. Founded in 2018 by researchers from the Barcelona Supercomputing Center, ELEM has developed a suite of simulation tools known as Alya Red. This platform operates on a Software-as-a-Service model and is designed for the medical device and pharmaceutical industries. Alya Red allows for the simulation of cardiovascular and respiratory systems on virtual patients, utilizing high-performance computing, computational biomechanics, and data analysis. These virtual avatars enable biomedical companies and healthcare professionals to enhance diagnostics, plan treatments, optimize drug delivery, and improve medical devices.

Ganymed Robotics SAS, established in 2018 and headquartered in Paris, France, specializes in the development of advanced robotics technologies tailored for orthopedic surgeons. The company's primary focus is on creating a therapeutic device designed to enhance surgical precision during knee replacement procedures. This innovative technology aims to improve patient outcomes, surgeon experience, and overall efficiency of care delivery by leveraging robotic assistance to reduce operating time.

Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

C12 Quantum Electronics is a company based in Paris, Ile-de-France, France, founded in 2019 by Pierre and Matthieu Desjardins. The company focuses on developing reliable quantum processors utilizing carbon nanotubes, which significantly reduce error rates. This technology positions C12 Quantum Electronics as a strong candidate for noisy intermediate-scale quantum applications. In addition to building quantum computers, the company also engages in developing and accelerating experiments related to information processing systems, allowing industrial clients to leverage intermediate-scale quantum applications for enhanced computing capabilities.

Qarnot is a French company headquartered in Montrouge, founded in 2010, that specializes in providing economical and ecological high-performance computing (HPC) solutions. It has developed an innovative product known as the Q.rad, a computing heater that integrates microprocessors to generate heat while performing computational tasks. This dual-function device serves as both an electrical heater and a powerful computing server, allowing users to manage temperature via an embedded thermostat or smartphone. By utilizing Q.rad, construction companies can meet their heating needs for new buildings while also benefiting from affordable HPC services, thus reducing costs associated with traditional data center infrastructure, maintenance, and cooling. Qarnot's approach not only offers a unique solution for heating but also promotes energy efficiency and sustainability in the tech industry.

Antabio is a private biopharmaceutical company based in Labege, France, focused on developing innovative treatments for drug-resistant infections, particularly targeting critical priority pathogens. Founded in 2009, the company specializes in creating novel antibacterial resistance-breakers, including stand-alone inhibitors of bacterial metalloenzymes. These inhibitors are designed to be combined with existing antibiotics, such as carbapenems, to restore their efficacy against the most challenging pathogens responsible for life-threatening infections, including carbapenem-resistant nosocomial pneumonia. Antabio aims to address significant unmet medical needs in the treatment of drug-resistant infections, ultimately providing healthcare professionals with effective medicinal products to combat these critical health challenges. The company has been recognized for its work, receiving a Wellcome Trust Seeding Drug Discovery Award.

Quanturi Oy is a Finnish company founded in 2016, headquartered in Espoo, with additional locations across Europe, including France, Great Britain, the Netherlands, Switzerland, Italy, and Belgium. The company specializes in developing and providing continuous monitoring solutions for fermentable products, focusing on sectors such as agriculture, forestry, and waste management. Its product offerings include wireless monitoring systems for compost temperature, grain management, and hay, as well as temperature monitoring systems applicable to various other industries. Quanturi Oy also engages in online sales of its innovative solutions, emphasizing the analysis of data associated with its connected objects.

Quanturi Oy is a Finnish company founded in 2016, headquartered in Espoo, with additional locations across Europe, including France, Great Britain, the Netherlands, Switzerland, Italy, and Belgium. The company specializes in developing and providing continuous monitoring solutions for fermentable products, focusing on sectors such as agriculture, forestry, and waste management. Its product offerings include wireless monitoring systems for compost temperature, grain management, and hay, as well as temperature monitoring systems applicable to various other industries. Quanturi Oy also engages in online sales of its innovative solutions, emphasizing the analysis of data associated with its connected objects.

Abzu is a company that develops a scientific artificial intelligence platform aimed at accelerating drug discovery and bringing pharmaceuticals to market more efficiently. Founded in January 2018, with offices in Copenhagen, Denmark, and Barcelona, Spain, Abzu challenges traditional, opaque AI methods by utilizing its pioneering technology, the QLattice. This platform provides transparent and explainable models that enable data scientists to approach their work with a scientific mindset. By unlocking new disease mechanisms, discovering novel biomarkers, and designing improved drugs, Abzu empowers pharmaceutical and biotech companies to validate multiple targets simultaneously, thereby enhancing their research capabilities and reducing development costs.

Antabio is a private biopharmaceutical company based in Labege, France, focused on developing innovative treatments for drug-resistant infections, particularly targeting critical priority pathogens. Founded in 2009, the company specializes in creating novel antibacterial resistance-breakers, including stand-alone inhibitors of bacterial metalloenzymes. These inhibitors are designed to be combined with existing antibiotics, such as carbapenems, to restore their efficacy against the most challenging pathogens responsible for life-threatening infections, including carbapenem-resistant nosocomial pneumonia. Antabio aims to address significant unmet medical needs in the treatment of drug-resistant infections, ultimately providing healthcare professionals with effective medicinal products to combat these critical health challenges. The company has been recognized for its work, receiving a Wellcome Trust Seeding Drug Discovery Award.

C2C NewCap, founded in 2014 by Rui Silva and Andre Mao de Ferro, is a Lisbon-based manufacturer specializing in the production of supercapacitors designed for efficient electrical energy storage. The company focuses on developing next-generation devices that utilize proprietary electrodes and an aqueous electrolyte, which contribute to a low environmental impact. C2C NewCap aims to provide clients with energy storage solutions that not only enhance operational efficiency but also reduce overall environmental and operational costs.

SiPearl is a French semiconductor company established in 2019 and headquartered in Maisons-Laffitte, Île-de-France. The company specializes in designing high-performance, low-power microprocessors aimed at powering exascale supercomputers. Its flagship product, Rhea, is based on the Arm Neoverse V1 architecture and is set to be commercialized in early 2024. SiPearl's microprocessors are intended for a variety of applications, including computing, artificial intelligence, medical research, climate change mitigation, and energy management, catering to scientific researchers as well as prominent players in the IT, electronics, and automotive industries. The company is committed to producing its microprocessors using advanced manufacturing processes from TSMC, specifically N6 or better. SiPearl also maintains research and development centers across France, Germany, and Spain, aligning its roadmap with the European Union's technological goals.

SiPearl is a French semiconductor company established in 2019 and headquartered in Maisons-Laffitte, Île-de-France. The company specializes in designing high-performance, low-power microprocessors aimed at powering exascale supercomputers. Its flagship product, Rhea, is based on the Arm Neoverse V1 architecture and is set to be commercialized in early 2024. SiPearl's microprocessors are intended for a variety of applications, including computing, artificial intelligence, medical research, climate change mitigation, and energy management, catering to scientific researchers as well as prominent players in the IT, electronics, and automotive industries. The company is committed to producing its microprocessors using advanced manufacturing processes from TSMC, specifically N6 or better. SiPearl also maintains research and development centers across France, Germany, and Spain, aligning its roadmap with the European Union's technological goals.

Qubit Pharmaceuticals is a Paris-based company established in 2020, focusing on innovative technology for pharmaceutical drug discovery. Founded by prominent academic institutions and researchers, including CNAM, CNRS, the University of Texas at Austin, Sorbonne University, and Washington University, the company leverages over 20 years of research and development. Qubit Pharmaceuticals has developed a drug discovery simulation platform that aims to significantly reduce the cost and duration of preclinical drug development. Utilizing proprietary force field models and molecular dynamics calculations, the platform facilitates virtual screening and visualization of potential drug candidates. By integrating principles of quantum physics, Qubit Pharmaceuticals supports biopharmaceutical companies in accelerating their research and development processes, ultimately enhancing the efficiency of drug discovery.

Core Biogenesis is a biotechnology company based in Paris, France, founded in 2020. It specializes in developing next-generation recombinant protein production technologies that utilize proprietary gene editing and plant biotechnology. The company aims to significantly lower the cost of producing growth factors, which are essential molecules used in the clean meat and cell therapy industries. Core Biogenesis employs an ultra-scalable bioproduction as a service (UBaaS) platform, allowing for the efficient mass production of valuable bioproducts by using plants as biofactories. This innovative approach enhances the speed and scalability of molecule extraction while enabling clients in the healthcare sector to improve cell growth, division, and survival, ultimately increasing yields and reducing costs.

Ignion is an antenna innovator based in Sant Cugat del Vallès, Spain, founded in 2015. The company specializes in the manufacturing of multiband, multipurpose antennas designed to address mobile and wireless connectivity needs. Ignion provides off-the-shelf antennas that cater to the Internet of Things and short-range wireless devices, particularly suited for indoor environments. Their products are designed for easy and efficient integration into industrial designs, enabling clients to meet their connectivity requirements effectively.

Core Biogenesis is a biotechnology company based in Paris, France, founded in 2020. It specializes in developing next-generation recombinant protein production technologies that utilize proprietary gene editing and plant biotechnology. The company aims to significantly lower the cost of producing growth factors, which are essential molecules used in the clean meat and cell therapy industries. Core Biogenesis employs an ultra-scalable bioproduction as a service (UBaaS) platform, allowing for the efficient mass production of valuable bioproducts by using plants as biofactories. This innovative approach enhances the speed and scalability of molecule extraction while enabling clients in the healthcare sector to improve cell growth, division, and survival, ultimately increasing yields and reducing costs.

Easyl is a manufacturer based in Bonneville, France, specializing in the sustainable production of materials for zinc-based batteries. Founded in 2017, the company employs green chemistry to create composites primarily using calcium zincate. This innovative approach allows Easyl to develop advanced electrodes that enhance the performance of batteries by optimizing their electrochemical characteristics. By focusing on environmentally friendly methods, Easyl aims to contribute to the growing demand for sustainable energy solutions in the battery manufacturing industry.

Scipio Bioscience SAS is a biotechnology company based in Paris, France, founded in 2017. It specializes in manufacturing benchtop kits that provide innovative sample preparation solutions for single-cell studies. These kits are designed for use in sequencing applications across both clinical and basic research, with a particular focus on transcriptomics. Scipio Bioscience's products enable research laboratories to perform single-cell barcoding in a test tube format, facilitating more precise and efficient analysis in various scientific investigations.

Ignion is an antenna innovator based in Sant Cugat del Vallès, Spain, founded in 2015. The company specializes in the manufacturing of multiband, multipurpose antennas designed to address mobile and wireless connectivity needs. Ignion provides off-the-shelf antennas that cater to the Internet of Things and short-range wireless devices, particularly suited for indoor environments. Their products are designed for easy and efficient integration into industrial designs, enabling clients to meet their connectivity requirements effectively.

Scipio Bioscience SAS is a biotechnology company based in Paris, France, founded in 2017. It specializes in manufacturing benchtop kits that provide innovative sample preparation solutions for single-cell studies. These kits are designed for use in sequencing applications across both clinical and basic research, with a particular focus on transcriptomics. Scipio Bioscience's products enable research laboratories to perform single-cell barcoding in a test tube format, facilitating more precise and efficient analysis in various scientific investigations.

Dracula Technologies SAS is a pioneer in the field of sustainable energy, specializing in organic photovoltaic technology. Founded in 2011 and headquartered in Valence, France, the company designs and manufactures organic photovoltaic cells that enable small devices, such as smartphones, GPS units, and lamps, to harness energy from various light sources for self-recharging. Their flagship product, Light As Your Energetic Response (LAYER), effectively captures both indoor and outdoor light to convert it into electricity. By utilizing innovative digital printing techniques, Dracula Technologies produces lightweight modules that can be integrated into a wide range of electronic devices, including sensors and asset tracking systems. This technology not only addresses the limitations of conventional batteries but also enhances the reliability and operational lifespan of wireless sensor networks. As a subsidiary of Ardeje, Dracula Technologies positions itself as a key player in sustainable energy solutions for low-power devices.

CAILabs SAS is a French deep tech company headquartered in Rennes, specializing in the design, development, and production of photonic solutions aimed at optimizing light utilization in various applications. Established in 2013, CAILabs focuses on innovative optical components, particularly through its patented Multi-Plane Light Conversion (MPLC) technology. The company provides a range of products, including mode multiplexers, light converters, and laser beam shaping solutions tailored for the telecommunications and industrial laser sectors. Its offerings are designed to enhance the performance of fiber optic networks and laser material processing, addressing critical challenges such as atmospheric turbulence and the need for efficient signal multiplexing. CAILabs aims to leverage its expertise and technological innovations to create reliable and cost-effective solutions for clients in the photonics industry.

PeekMed is a company based in Braga, Portugal, specializing in 3D pre-operative planning software for orthopedic surgery. Founded in 2015 by Jaime Campos, Sara Silva, and João Pedro Ribeiro, the company aims to enhance surgical outcomes while minimizing costs. Its software facilitates intuitive surgical planning for various orthopedic procedures, including total joint replacements, osteotomies, and fracture reductions. PeekMed's system allows orthopedic surgeons to effectively plan surgeries by enabling precise correction of bone deformities and supporting trauma case management. The software also provides tools for storing patient studies and reports, allowing easy access to medical images from local servers. Additionally, the output from PeekMed's planning system can be integrated with navigation systems, 3D printers, robotics, and mobile devices, further improving surgical precision and efficiency.

SAALG Geomechanics SL is a Barcelona-based engineering company established in 2016, specializing in advanced geological and numerical services for the construction industry. The company develops software that facilitates real-time analysis of ground conditions during civil works and building projects, employing machine learning and data analysis technology to monitor and anticipate potential risks related to ground movement. SAALG Geomechanics offers a range of services, including numerical model calibrations, soil and rock parameter characterization through back-analysis, and both 2D and 3D geomechanical and geotechnical simulations. Their expertise is particularly focused on applications such as TBM tunnel excavations, conventional tunnels, large and deep excavations, and reinforced earth retaining walls. Through its innovative solutions, SAALG Geomechanics aims to bridge the gap between academic research in geomechanics and practical applications in the industry, enabling clients to optimize construction projects and enhance safety and efficiency.

Core Biogenesis is a biotechnology company based in Paris, France, founded in 2020. It specializes in developing next-generation recombinant protein production technologies that utilize proprietary gene editing and plant biotechnology. The company aims to significantly lower the cost of producing growth factors, which are essential molecules used in the clean meat and cell therapy industries. Core Biogenesis employs an ultra-scalable bioproduction as a service (UBaaS) platform, allowing for the efficient mass production of valuable bioproducts by using plants as biofactories. This innovative approach enhances the speed and scalability of molecule extraction while enabling clients in the healthcare sector to improve cell growth, division, and survival, ultimately increasing yields and reducing costs.

SAALG Geomechanics SL is a Barcelona-based engineering company established in 2016, specializing in advanced geological and numerical services for the construction industry. The company develops software that facilitates real-time analysis of ground conditions during civil works and building projects, employing machine learning and data analysis technology to monitor and anticipate potential risks related to ground movement. SAALG Geomechanics offers a range of services, including numerical model calibrations, soil and rock parameter characterization through back-analysis, and both 2D and 3D geomechanical and geotechnical simulations. Their expertise is particularly focused on applications such as TBM tunnel excavations, conventional tunnels, large and deep excavations, and reinforced earth retaining walls. Through its innovative solutions, SAALG Geomechanics aims to bridge the gap between academic research in geomechanics and practical applications in the industry, enabling clients to optimize construction projects and enhance safety and efficiency.

Multiverse Computing SL is a software development company based in San Sebastian, Spain, with an additional office in Toronto, Canada. Established in 2019, the company specializes in creating quantum computing software that leverages probabilistic and nondeterministic technologies to address complex challenges in various sectors, particularly finance. Multiverse Computing's software solutions are designed for portfolio optimization, risk analysis, and market simulation, enabling clients in industries such as banking, energy, manufacturing, and logistics to harness the power of quantum computing. By focusing on these tailored applications, the company aims to facilitate advancements in solving financial and macro-economic problems, positioning itself as a key player in the emerging quantum technology landscape.

Multiverse Computing SL is a software development company based in San Sebastian, Spain, with an additional office in Toronto, Canada. Established in 2019, the company specializes in creating quantum computing software that leverages probabilistic and nondeterministic technologies to address complex challenges in various sectors, particularly finance. Multiverse Computing's software solutions are designed for portfolio optimization, risk analysis, and market simulation, enabling clients in industries such as banking, energy, manufacturing, and logistics to harness the power of quantum computing. By focusing on these tailored applications, the company aims to facilitate advancements in solving financial and macro-economic problems, positioning itself as a key player in the emerging quantum technology landscape.

Aortyx is a pioneering company founded by researchers from the IQS School of Engineering and the Hospital Clínic de Barcelona. It specializes in developing endovascular devices designed to treat aortic diseases. The company's technology centers on tissue regeneration by replicating the biomechanical environment of the aorta, creating an optimal setting for cell migration and proliferation within a bioresorbable platform. This approach aims to closely mimic the natural dynamics of the aorta, thereby enhancing the efficiency of vascular disease treatment.

CARTO is a leading Location Intelligence platform that specializes in transforming spatial data into actionable insights for businesses. Founded in 2012 by an environmental scientist and visualization experts, the company is headquartered in New York City, with additional offices in Madrid, Seville, and Washington, DC. CARTO provides a cloud-based mapping, analysis, and visualization engine that enables data scientists, developers, and analysts to tackle spatial problems, optimize business processes, and predict outcomes. Its services facilitate more efficient delivery routes, enhanced behavioral marketing, and strategic store placements. With a customer base of 2,500, including notable companies like Mastercard, Vodafone, and Coca-Cola, CARTO has established itself as a significant player in the field. The company employs around 130 people and has garnered recognition from industry leaders such as G2, Gartner, and Forrester for its innovative contributions to Location Intelligence.

Daze is an engineering startup focused on creating innovative solutions for electric vehicle charging. Its flagship product, DazePlug, is an automatic charging device that utilizes smart charging ecosystems and energy management systems. This technology enables automatic inductive charging, significantly reducing the time required to charge electric vehicles while eliminating the need for manual handling of cables. DazePlug features a retrofit design that is both waterproof and dustproof, ensuring durability and ease of use. By simplifying the charging process, Daze aims to enhance user experience and convenience for electric vehicle owners.

Criam is a biotechnology company based in Braga, Portugal, founded in 2015. It specializes in the research and development of a medical device that facilitates blood type analysis and the detection of various infectious diseases, including HIV, Brucella, tick fever, syphilis, mononucleosis, and meningitis. The company's portable platform operates independently of electricity and does not require additional laboratory infrastructure, making it accessible for use in diverse settings. Criam's device allows for rapid and accurate blood testing, which enhances clinical decision-making by providing timely health information. The technology is designed to be scalable, with one reader capable of performing multiple tests using specialized cartridges and computer vision algorithms. This innovation aims to improve the efficiency and reliability of blood testing services, ultimately enhancing patient care.

EVerZom is a nanomedicine biotech company based in Paris, France, that specializes in the large-scale manufacturing of extracellular vesicles, including exosomes, microvesicles, and apoptotic bodies. Founded in 2019, the company has developed a proprietary bioproduction platform that complies with Good Manufacturing Practice (GMP) standards, aimed at pharmaceutical companies. EVerZom's technology focuses on producing extracellular vesicles for applications in regenerative medicine and drug delivery, leveraging their protective and reparative properties. This innovative approach provides healthcare professionals with a valuable therapeutic tool to address organ failure and restore function and homeostasis in patients.

Voiseed is an Italian startup focused on artificial intelligence in synthetic speech technology. The company has developed a fast and scalable AI Dubbing Platform specifically for the video game industry, enabling the creation of virtual human voices that mimic human emotions and prosody. This cloud-based software leverages advanced generative AI technologies to produce highly expressive virtual voices, allowing creators to customize vocal expressions and achieve multilingual voice conversion for various projects. By streamlining the dubbing process, Voiseed aims to reduce costs, time, and complexity, while continuously expanding its features to cater to additional sectors beyond gaming.

Ganymed Robotics SAS, established in 2018 and headquartered in Paris, France, specializes in the development of advanced robotics technologies tailored for orthopedic surgeons. The company's primary focus is on creating a therapeutic device designed to enhance surgical precision during knee replacement procedures. This innovative technology aims to improve patient outcomes, surgeon experience, and overall efficiency of care delivery by leveraging robotic assistance to reduce operating time.

Enersens is a firm that produces silica aerogel products. The company was founded in 2010 and is based in Les Auvergnes, France.

NETRIS Pharma S.A.S. is a biotechnology company based in Lyon, France, focused on the identification and development of therapeutic molecules aimed at treating various forms of cancer. Established in 2008, the company specializes in targeting dependence receptors, which are trans-membrane proteins that play a crucial role in cellular signaling and tumor control. NETRIS Pharma conducts both in vitro and in vivo research, as well as preclinical practices, to manufacture drugs specifically for the treatment of breast cancer, lung cancer, glioblastoma, and neuroblastoma. Through its innovative approach, the company aims to advance cancer therapies and contribute to improved patient outcomes in the pharmaceutical industry.

Wooptix S.L., founded in 2014 and headquartered in Madrid, Spain, specializes in developing advanced imaging technologies. The company focuses on light field and wavefront phase imaging software that captures comprehensive information about light, utilizing the full resolution of sensors. Wooptix's platform enables the three-dimensional modulation of images, allowing for higher data points at elevated frame rates in volumetric images and videos. This technology facilitates enhanced image quality and advanced post-processing capabilities, providing users with innovative ways to interact with and visualize their environments. Wooptix aims to improve human experiences through its cutting-edge imaging solutions.

NETRIS Pharma S.A.S. is a biotechnology company based in Lyon, France, focused on the identification and development of therapeutic molecules aimed at treating various forms of cancer. Established in 2008, the company specializes in targeting dependence receptors, which are trans-membrane proteins that play a crucial role in cellular signaling and tumor control. NETRIS Pharma conducts both in vitro and in vivo research, as well as preclinical practices, to manufacture drugs specifically for the treatment of breast cancer, lung cancer, glioblastoma, and neuroblastoma. Through its innovative approach, the company aims to advance cancer therapies and contribute to improved patient outcomes in the pharmaceutical industry.

MYSPHERA SL is a company based in Paterna, Spain, that specializes in developing location and process visibility solutions for the healthcare sector using Internet of Things (IoT) technology and real-time location systems (RTLS). Established in 2012, MYSPHERA offers a range of IoT devices and applications designed to enhance patient care and operational efficiency in acute care hospitals, senior living facilities, and patient homes. Its solutions include tracking systems for residents and nursing services, as well as alerts for patients. The company also provides various web applications, such as MYHOSPITAL, MYNURSING, and MYLOCS, which assist healthcare professionals and administrators in managing services effectively. By delivering actionable insights through smart sensors, MYSPHERA aims to improve patient outcomes and optimize resource management across healthcare organizations in Europe, the Middle East, and Latin America.

SiPearl is a French semiconductor company established in 2019 and headquartered in Maisons-Laffitte, Île-de-France. The company specializes in designing high-performance, low-power microprocessors aimed at powering exascale supercomputers. Its flagship product, Rhea, is based on the Arm Neoverse V1 architecture and is set to be commercialized in early 2024. SiPearl's microprocessors are intended for a variety of applications, including computing, artificial intelligence, medical research, climate change mitigation, and energy management, catering to scientific researchers as well as prominent players in the IT, electronics, and automotive industries. The company is committed to producing its microprocessors using advanced manufacturing processes from TSMC, specifically N6 or better. SiPearl also maintains research and development centers across France, Germany, and Spain, aligning its roadmap with the European Union's technological goals.

MYSPHERA SL is a company based in Paterna, Spain, that specializes in developing location and process visibility solutions for the healthcare sector using Internet of Things (IoT) technology and real-time location systems (RTLS). Established in 2012, MYSPHERA offers a range of IoT devices and applications designed to enhance patient care and operational efficiency in acute care hospitals, senior living facilities, and patient homes. Its solutions include tracking systems for residents and nursing services, as well as alerts for patients. The company also provides various web applications, such as MYHOSPITAL, MYNURSING, and MYLOCS, which assist healthcare professionals and administrators in managing services effectively. By delivering actionable insights through smart sensors, MYSPHERA aims to improve patient outcomes and optimize resource management across healthcare organizations in Europe, the Middle East, and Latin America.

APIX Analytics is a company specializing in the development and marketing of advanced gas analyzer systems. Founded in 2014 and based in Grenoble, France, APIX Analytics focuses on creating miniaturized multigas analyzers using nano-silicon technology. These systems are designed for industrial, environmental, and security applications, integrating analytical chains such as sampling, gas injection, and separation of complex gas mixtures to enhance specificity and detection. The company's technology aims to improve the identification and quantification of each compound in a mixture, thereby increasing safety and quality requirements for various industries, including renewable energy development.

Spika Tech is a technology-focused company based in Madrid, Spain, founded in 2015. It specializes in research and development, providing comprehensive support for projects in various technological sectors. The company offers a wide range of services, including virtual and augmented reality, the development of complex software applications, and artificial intelligence solutions. Additionally, Spika Tech assists clients with branding and design needs, such as creating logos, corporate identities, presentations, websites, applications, and online stores. By leveraging the latest techniques in design and programming, Spika Tech aims to enhance the quality and effectiveness of its clients' development processes.

Wooptix S.L., founded in 2014 and headquartered in Madrid, Spain, specializes in developing advanced imaging technologies. The company focuses on light field and wavefront phase imaging software that captures comprehensive information about light, utilizing the full resolution of sensors. Wooptix's platform enables the three-dimensional modulation of images, allowing for higher data points at elevated frame rates in volumetric images and videos. This technology facilitates enhanced image quality and advanced post-processing capabilities, providing users with innovative ways to interact with and visualize their environments. Wooptix aims to improve human experiences through its cutting-edge imaging solutions.

Spika Tech is a technology-focused company based in Madrid, Spain, founded in 2015. It specializes in research and development, providing comprehensive support for projects in various technological sectors. The company offers a wide range of services, including virtual and augmented reality, the development of complex software applications, and artificial intelligence solutions. Additionally, Spika Tech assists clients with branding and design needs, such as creating logos, corporate identities, presentations, websites, applications, and online stores. By leveraging the latest techniques in design and programming, Spika Tech aims to enhance the quality and effectiveness of its clients' development processes.

SiPearl is a French semiconductor company established in 2019 and headquartered in Maisons-Laffitte, Île-de-France. The company specializes in designing high-performance, low-power microprocessors aimed at powering exascale supercomputers. Its flagship product, Rhea, is based on the Arm Neoverse V1 architecture and is set to be commercialized in early 2024. SiPearl's microprocessors are intended for a variety of applications, including computing, artificial intelligence, medical research, climate change mitigation, and energy management, catering to scientific researchers as well as prominent players in the IT, electronics, and automotive industries. The company is committed to producing its microprocessors using advanced manufacturing processes from TSMC, specifically N6 or better. SiPearl also maintains research and development centers across France, Germany, and Spain, aligning its roadmap with the European Union's technological goals.

Palobiofarma is a Spanish biotechnology company based in Barcelona’s Science Park, dedicated to discovering and developing innovative drugs that target adenosine receptors. The company aims to be the first European entity to bring an adenosine modulator to market, focusing on the treatment of diseases such as advanced prostate cancer. Through its expertise in medicinal chemistry and in vitro pharmacology, Palobiofarma is committed to advancing the understanding of adenosine's role in disease and enabling healthcare professionals to improve patient outcomes through novel therapeutic options.

Epigene Labs SAS is a biotechnology firm focused on enhancing precision oncology through its advanced technology platform that utilizes artificial intelligence. Founded in 2019 and headquartered in Paris, France, with an additional office in Boston, Massachusetts, the company addresses the significant challenges of aggregating, analyzing, and visualizing extensive genomic data in cancer research. By integrating proprietary data from partners with publicly available datasets, Epigene Labs provides medical researchers with actionable insights and user-friendly analytics. The company collaborates with leading cancer centers and prominent biotech firms to develop intelligence-augmenting services that support drug discovery and research in precision oncology. Its innovative approach aims to transform genomic data into effective strategies for targeted cancer therapies.

Enersens is a firm that produces silica aerogel products. The company was founded in 2010 and is based in Les Auvergnes, France.

Palobiofarma is a Spanish biotechnology company based in Barcelona’s Science Park, dedicated to discovering and developing innovative drugs that target adenosine receptors. The company aims to be the first European entity to bring an adenosine modulator to market, focusing on the treatment of diseases such as advanced prostate cancer. Through its expertise in medicinal chemistry and in vitro pharmacology, Palobiofarma is committed to advancing the understanding of adenosine's role in disease and enabling healthcare professionals to improve patient outcomes through novel therapeutic options.

PKvitality is a bio-wearable company based in Paris, France, that specializes in innovative health monitoring solutions. Founded in 2017, the company has developed K’Track, a line of trackers that assess key physiological markers through skin analysis, eliminating the need for blood samples. Its flagship product, K’Watch Glucose, is a continuous glucose monitoring device designed in the form of a smartwatch, featuring a micro-needle sensor that allows diabetics to monitor their glucose levels painlessly and discreetly. The device provides real-time alerts through on-body vibrations for hypo or hyperglycemic episodes, enhancing user convenience and safety. In addition to glucose monitoring, PKvitality is expanding its offerings to include continuous lactate monitoring and multi-analyte monitors, further advancing the field of wearable health technology.

Aenitis Technologies is a French start-up founded in July 2014 by researchers Mauricio Hoyos and Jean-Luc Aider from the CNRS. The company specializes in the development of innovative medical devices that address challenges in cell therapy preparation and bioprocessing. Aenitis Technologies focuses on solutions for cell sorting, washing, and isolation, utilizing acoustophoresis technologies to enhance the efficiency of these processes. With an emphasis on revolutionizing practices in public health, Aenitis Technologies aims to establish itself as a world leader in the separation and filtration of biological elements, providing vital support to cell therapy units and blood banks in the healthcare industry.

Oledcomm is a Paris-based company that specializes in the design and development of LiFi solutions, which utilize light for high-speed optical wireless data communication. Founded in 2012 and re-established in February 2020 by Benjamin Azoulay, Oledcomm's product portfolio includes LiFi transceivers, software, and various solutions aimed at the aerospace and industrial markets. The company's technology offers an environmentally friendly alternative to traditional wireless communication methods, allowing for seamless connectivity across a range of applications, including telecommunications, data communications, and personal electronics. Through innovative optical networking products, Oledcomm facilitates the conversion of information into binary data, akin to an optical Morse code, enhancing the efficiency and speed of data transmission.

Oledcomm is a Paris-based company that specializes in the design and development of LiFi solutions, which utilize light for high-speed optical wireless data communication. Founded in 2012 and re-established in February 2020 by Benjamin Azoulay, Oledcomm's product portfolio includes LiFi transceivers, software, and various solutions aimed at the aerospace and industrial markets. The company's technology offers an environmentally friendly alternative to traditional wireless communication methods, allowing for seamless connectivity across a range of applications, including telecommunications, data communications, and personal electronics. Through innovative optical networking products, Oledcomm facilitates the conversion of information into binary data, akin to an optical Morse code, enhancing the efficiency and speed of data transmission.

Sabi Agri is an agricultural engineering company based in Saint-Beauzire, France, founded in 2017. The company specializes in designing and manufacturing electric tractors tailored to meet the diverse needs of modern agriculture. Sabi Agri's products are suitable for a range of agricultural projects, including market gardening, livestock farming, field crops, viticulture, and arboriculture. By offering innovative electrical equipment and technology, Sabi Agri aims to support sustainable farming practices, enabling farmers to adopt cost-effective agroecological solutions.